Sorrento Therapeutics, Inc.
SRNE · OTC
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$578 | -$429 | -$314 | -$363 |
| Dep. & Amort. | $13 | $12 | $11 | $11 |
| Deferred Tax | -$2 | -$36 | -$2 | -$0 |
| Stock-Based Comp. | $75 | $90 | $31 | $13 |
| Change in WC | $70 | -$3 | $4 | $7 |
| Other Non-Cash | $128 | $83 | $111 | $160 |
| Operating Cash Flow | -$294 | -$282 | -$160 | -$173 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$14 | -$9 | -$38 | -$11 |
| Net Acquisitions | -$15 | -$1 | -$2 | -$10 |
| Inv. Purchases | $0 | -$35 | $0 | -$10 |
| Inv. Sales/Matur. | $0 | $125 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | -$7 |
| Investing Cash Flow | -$29 | $80 | -$40 | -$38 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$92 | -$36 | -$187 | $22 |
| Stock Issued | $402 | $202 | $318 | $48 |
| Stock Repurch. | $0 | $0 | -$55 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $2 | $15 | $98 | $9 |
| Financing Cash Flow | $312 | $181 | $174 | $79 |
| Forex Effect | -$2 | $1 | $1 | -$0 |
| Net Chg. in Cash | -$13 | -$20 | -$24 | -$133 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $37 | $56 | $81 | $213 |
| End Cash | $24 | $37 | $56 | $81 |
| Free Cash Flow | -$308 | -$291 | -$197 | -$184 |